Bulletin
Investor Alert

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

After Hours

 --Real time quotes

Jul 2, 2020, 6:20 p.m.

/zigman2/quotes/209129655/composite

$

6.99

Change

+0.03 +0.43%

Volume

Volume 20,919

Real time quotes

/zigman2/quotes/209129655/composite

Today's close

$ 7.01

$ 6.96

Change

-0.05 -0.71%

Day low

Day high

$6.89

$7.28

Open

52 week low

52 week high

$2.43

$48.48

Open

Company Description

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extract...

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

Valuation

Price to Sales Ratio

10.31

Price to Book Ratio

6.17

Enterprise Value to EBITDA

-6.80

Enterprise Value to Sales

6.97

Total Debt to Enterprise Value

0.22

Efficiency

Revenue/Employee

101,445.00

Income Per Employee

-195,121.00

Receivables Turnover

5.52

Total Asset Turnover

0.22

Liquidity

Current Ratio

2.80

Quick Ratio

1.85

Cash Ratio

1.05

Profitability

Gross Margin

-21.02

Operating Margin

-129.69

Pretax Margin

-194.70

Net Margin

-192.34

Return on Assets

-41.36

Return on Equity

-133.01

Return on Total Capital

-31.36

Return on Invested Capital

-46.66

Capital Structure

Total Debt to Total Equity

164.46

Total Debt to Total Capital

62.19

Total Debt to Total Assets

52.34

Long-Term Debt to Equity

163.07

Long-Term Debt to Total Capital

61.66

Officers and Executives

Name Age Officer Since Title
Mr. Brendan Kennedy 46 2018 President, Chief Executive Officer & Director
Mr. Jon Levin 50 2020 Chief Operating Officer
Mr. Michael Kruteck 54 2020 Chief Financial Officer
Mr. Cuba Flowers - 2016
Dr. Joshua Eades - 2014 Chief Science Officer & Vice President

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/18/2020 Andrew Pucher
Chief Corporate Dev Officer
4,009   Derivative/Non-derivative trans. at $0 per share. 0
06/18/2020 Andrew Pucher
Chief Corporate Dev Officer
7,497   Derivative/Non-derivative trans. at $0 per share. 0
06/17/2020 Brendan Kennedy
President and CEO; Director
116,666   Disposition at $8.04 per share. 937,994
06/16/2020 Brendan Kennedy
President and CEO; Director
116,666   Disposition at $8.34 per share. 972,994
06/05/2020 Michael Shtender-Auerbach
Director
10,475   0
06/05/2020 Michael Shtender-Auerbach
Director
210,710   0
06/05/2020 Michael Shtender-Auerbach
Director
57,159   0
06/05/2020 Michael Shtender-Auerbach
Director
538,706   0
06/01/2020 Maryscott Greenwood
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
06/01/2020 Rebekah Dopp
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
06/01/2020 Christine Thompson St. Clare
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Michael Shtender-Auerbach
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Maryscott Greenwood
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Rebekah Dopp
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Christine Thompson St. Clare
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2020 Michael Shtender-Auerbach
Director
125,580   Disposition at $7.38 per share. 926,780
05/01/2020 Michael Shtender-Auerbach
Director
95,131   Disposition at $7.38 per share. 702,066
05/01/2020 Michael Shtender-Auerbach
Director
18,290   Derivative/Non-derivative trans. at $0.19 per share. 3,475
05/01/2020 Michael Shtender-Auerbach
Director
107,290   Derivative/Non-derivative trans. at $0.19 per share. 20,385
04/06/2020 Michael Shtender-Auerbach
Director
1,069   0
04/06/2020 Michael Shtender-Auerbach
Director
6,822   0
04/06/2020 Michael Shtender-Auerbach
Director
425,235   0
04/06/2020 Michael Shtender-Auerbach
Director
166,326   0
04/01/2020 Brendan Kennedy
President and CEO; Director
11,415   Derivative/Non-derivative trans. at $5.9 per share. 67,348
04/01/2020 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2020 Michael Shtender-Auerbach
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2020 Edward Wood Pastorius
Chief Revenue Officer
6,250   Derivative/Non-derivative trans. at $0 per share. 0
03/18/2020 Andrew Pucher
Chief Corporate Dev Officer
16,072   Derivative/Non-derivative trans. at $2.47 per share. 39,697
03/18/2020 Andrew Pucher
Chief Corporate Dev Officer
30,024   Derivative/Non-derivative trans. at $0 per share. 0
/news/latest/company/us/tlry

MarketWatch News on TLRY

  1. U.S. Pot Producer Green Thumb Outsells Canada’s Aurora

    6:58 p.m. May 14, 2020

    - Bill Alpert

  2. Tilray stock price target raised to $6.50 from $5.50 at Stifel Nicolaus

    8:06 a.m. May 12, 2020

    - Tomi Kilgore

  3. Tilray says coronavirus has not dented operations

    7:15 a.m. May 12, 2020

    - Max A. Cherney

  4. Tilray's stock falls 5.9% premarket after Q1 results late Monday

    6:30 a.m. May 12, 2020

    - Tomi Kilgore

  5. Tilray stock price target cut to $14 from $28 at Benchmark

    6:17 a.m. May 12, 2020

    - Tomi Kilgore

  6. When to Expect Profits From Canada’s Pot Producers

    11:18 a.m. May 8, 2020

    - Bill Alpert

  7. Buy Marijuana Stock Aphria, Sell Tilray, Analysts Say

    12:03 p.m. April 16, 2020

    - Bill Alpert

  8. Cronos Has a Lot of Cash. That’s Attracting Investors.

    6:00 a.m. April 7, 2020

    - Connor Smith

  9. Loading more headlines...
/news/nonmarketwatch/company/us/tlry

Other News on TLRY

  1. Buy Canopy Growth Stock Before Positive Momentum Returns

    3:27 p.m. June 30, 2020

    - InvestorPlace.com

  2. Nikola Stock Charts Say Buy, Fundamentals Say Sell

    11:23 a.m. June 26, 2020

    - InvestorPlace.com

  3. Continue Avoiding Tilray Stock as Charts, Fundamentals Lag

    10:19 a.m. June 26, 2020

    - InvestorPlace.com

  4. How to Breathe Profits into Dead-Money CGC Stock

    8:38 a.m. June 26, 2020

    - InvestorPlace.com

  5. Tilray Shorts Just Keep Coming

    2:27 p.m. June 25, 2020

    - Seeking Alpha

  6. Cannabis Companies' Use Of Adjusted EBITDA Is A Ruse

    10:19 a.m. June 25, 2020

    - Seeking Alpha

  7. It's Time For Buried Cannabis Investors To Reallocate

    10:40 a.m. June 24, 2020

    - Seeking Alpha

  8. Don’t Let Positive Revenue Confuse Your Outlook on Tilray

    8:36 a.m. June 24, 2020

    - InvestorPlace.com

  9. Pot stocks rally on Aurora Cannabis reboot actions

    11:38 a.m. June 23, 2020

    - Seeking Alpha

  10. These Are Some of the Top CBD Stocks for the Next 10 Years

    8:26 a.m. June 23, 2020

    - Baystreet.ca

  11. Does Tilray Have the Right Stuff to Become a Global Leader?

    2:28 p.m. June 22, 2020

    - InvestorPlace.com

  12. Covido Ergo Zoom

    8:44 a.m. June 22, 2020

    - Seeking Alpha

  13. 7 Marijuana Stocks for Loyal Cannabis Bulls

    10:32 a.m. June 19, 2020

    - InvestorPlace.com

  14. Why Tilray Is Still a Very Risky Cannabis Stock

    9:19 a.m. June 19, 2020

    - InvestorPlace.com

  15. How I'm Betting Against Robinhood

    1:13 p.m. June 18, 2020

    - Seeking Alpha

  16. Tilray (TLRY) Gets a Hold Rating from Oppenheimer

    7:31 p.m. June 16, 2020

    - SmarterAnalyst

  17. Loading more headlines...

At a Glance

Tilray, Inc.

1100 Maughan Road

Nanaimo, British Columbia V9X IJ2

Phone

1 8448457291

Industry

Farming

Sector

Agriculture

Fiscal Year-end

12/2020

Revenue

$166.98M

Net Income

$-321.17M

2019 Sales Growth

287.2%

Employees

1,646

/news/pressrelease/company/us/tlry

Press Releases on TLRY

  1. Us Stocks That Surged Higher This Week: $LOW $TLRY $AMRN

    9:06 a.m. June 24, 2020

    - The Market Signal

  2. Cannabis Sales Surge During Lock Down

    9:06 a.m. June 24, 2020

    - CannabisNewsWire

  3. Cannabis Sales Surge During Lock Down

    9:01 a.m. June 24, 2020

    - NetworkNewsWire

  4. Cannabis Sales Surge During Lock Down

    8:30 a.m. June 24, 2020

    - PR Newswire - PRF

  5. Four CBD Stocks For The Last Half Of 2020

    8:00 a.m. June 24, 2020

    - GlobeNewswire

  6. Four CBD Stocks For The Last Half Of 2020

    8:00 a.m. June 24, 2020

    - GlobeNewswire

  7. Therapeutic Use of CBD Continues to Spread

    9:00 a.m. June 22, 2020

    - PR Newswire - PRF

  8. Therapeutic Approaches to Mental Wellness Now Include Psychedelics

    9:00 a.m. June 18, 2020

    - PR Newswire - PRF

  9. Stocks That Surged To 52-Week High: $TLRY $AMC $ENPH

    10:07 a.m. June 17, 2020

    - The Market Signal

  10. Positive First Steps Show the Promise of Psychedelic Therapies

    9:00 a.m. June 10, 2020

    - PR Newswire - PRF

  11. Tilray, Inc. to Participate in Two Upcoming Virtual Investor Events

    5:00 p.m. June 8, 2020

    - BusinessWire - BZX

  12. Momentum Builds Behind the Push for Psilocybin Decriminalization

    9:00 a.m. May 29, 2020

    - PR Newswire - PRF

  13. Tilray® Receives Complete GMP Certification at EU Campus

    8:00 a.m. May 27, 2020

    - BusinessWire - BZX

  14. Stocks Trading At Their Highest Volume: $BIOC $TLRY $TTOO

    9:19 a.m. May 25, 2020

    - The Market Signal

  15. Loading more headlines...
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.